01 FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE (2)
02 INFIGRATINIB PHOSPHATE (2)
03 MECHLORETHAMINE HYDROCHLORIDE (1)
04 NETUPITANT; PALONOSETRON HYDROCHLORIDE (1)
05 Netupitant; Palonosetron (1)
06 Nimesulide (4)
07 PALONOSETRON HYDROCHLORIDE (3)
08 Palonosetron (5)
09 Several substances refer to content (1)
10 palonosetronhydroklorid (2)
01 HELSINN (1)
02 HELSINN BIREX PHARMAC.LTD (6)
03 HELSINN HLTHCARE (8)
04 Helsinn Birex Pharmaceuticals Ltd. (3)
05 Helsinn Birex Solvay Ltd (4)
01 CAPSULE;ORAL (4)
02 Capsule, hard (1)
03 Capsule, soft (2)
04 GEL;TOPICAL (1)
05 HARD CAPSULES (1)
06 INJECTABLE;INTRAVENOUS (2)
07 Injection fluid, resolution (1)
08 Netupitant+Palonosetron 0,5+300Mg 1 Combined Oral Use (1)
09 Nimesulide 100Mg 30 Joined' Oral Use (2)
10 POWDER;INTRAVENOUS (1)
11 Palonosetron 250Mcg 5Ml 1 Units Parenteral Use (1)
12 SOFT CAPSULE (1)
13 SOLUTION FOR INJECTION (1)
14 SOLUTION;INTRAVENOUS (1)
15 Blank (2)
01 1 ampoule EV 250 mcg 5 ml (1)
02 1 cps 300 mg + 0.5 mg (1)
03 10 Supp 200 Mg (1)
04 100MG (1)
05 250 MICROGRAM (1)
06 250 mcg (1)
07 25MG (1)
08 30 Bust Grat 50 Mg (1)
09 30 CPR 100 mg (1)
10 30 bust grat 100 mg (1)
11 300 MG / 0.5 MG (1)
12 300 mg/0.5 mg (1)
13 300MG;EQ 0.5MG BASE (1)
14 500 MICROGRAMS (1)
15 500 mcg (2)
16 EQ 0.016% BASE (1)
17 EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
18 EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
19 EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
20 EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML) (1)
21 EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL (1)
01 Italy (6)
02 Norway (4)
03 Sweden (3)
04 USA (9)